Keystone Dental, a company focused on developing dental surgical and prosthetic technology, signed a definitive agreement to be acquired by Accelmed, an investment firm. Details of the acquisition were not disclosed.
Here are five things to know.
1. Following the announcement of its acquisition, Keystone Dental CEO Michael Kehoe announced his plans to transition out of his post.
2. Mr. Kehoe cited personal reasons for his retirement. He will transition out of his position over the next several months.
3. Keystone Dental is the largest independent implant development organization in North America, with revenues topping $40 million annually.
4. Keystone Dental offers dental implants, biomaterials for oral surgery and digital dentistry tools.
5. "The acquisition of Keystone by Accelmed promises to catalyze the next phase of our company's evolution to becoming a leader in the dental market," said Mr. Kehoe. "In addition to providing the growth capital required to ensure our premier positioning in the dental implant market, we believe that our team will benefit immediately from Accelmed’s track record of identifying innovative technologies that will enable us to anticipate our customers’ emerging needs for their practices."
More articles on dentists:
Henry Schein appoints for 2 new directors, including former Staples CEO
American Academy of Pediatric Dentistry inducts 11 new board officers & trustees
Biolase regains position on Nasdaq listing: 4 things to know
Here are five things to know.
1. Following the announcement of its acquisition, Keystone Dental CEO Michael Kehoe announced his plans to transition out of his post.
2. Mr. Kehoe cited personal reasons for his retirement. He will transition out of his position over the next several months.
3. Keystone Dental is the largest independent implant development organization in North America, with revenues topping $40 million annually.
4. Keystone Dental offers dental implants, biomaterials for oral surgery and digital dentistry tools.
5. "The acquisition of Keystone by Accelmed promises to catalyze the next phase of our company's evolution to becoming a leader in the dental market," said Mr. Kehoe. "In addition to providing the growth capital required to ensure our premier positioning in the dental implant market, we believe that our team will benefit immediately from Accelmed’s track record of identifying innovative technologies that will enable us to anticipate our customers’ emerging needs for their practices."
More articles on dentists:
Henry Schein appoints for 2 new directors, including former Staples CEO
American Academy of Pediatric Dentistry inducts 11 new board officers & trustees
Biolase regains position on Nasdaq listing: 4 things to know